BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 652202)

  • 1. Erroneous clinical diagnosis of leg vein thrombosis in women on oral contraceptives.
    Barnes RW; Krapf T; Hoak JC
    Obstet Gynecol; 1978 May; 51(5):556-8. PubMed ID: 652202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should the pill be stopped preoperatively?
    Sue-Ling H; Hughes LE
    Br Med J (Clin Res Ed); 1988 Feb; 296(6620):447-8. PubMed ID: 3126855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to activated protein C, highly prevalent amongst users of oral contraceptives with venous thromboembolism.
    Bennet L; Odeberg H
    J Intern Med; 1998 Jul; 244(1):27-32. PubMed ID: 9698021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolic disease developing during oral contraceptive therapy in young females with antiphospholipid antibodies.
    Girolami A; Zanon E; Zanardi S; Saracino MA; Simioni P
    Blood Coagul Fibrinolysis; 1996 Jun; 7(4):497-501. PubMed ID: 8840004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the birth control pill and its relationship to thrombophlebitis.
    Julsrud ME
    J Am Podiatry Assoc; 1979 Jun; 69(6):376-82. PubMed ID: 448035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor V Leiden: should we screen oral contraceptive users and pregnant women?
    Vandenbroucke JP; van der Meer FJ; Helmerhorst FM; Rosendaal FR
    BMJ; 1996 Nov; 313(7065):1127-30. PubMed ID: 8916702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptives and venous thromboembolism: a case-control study designed to minimize detection bias.
    Realini JP; Encarnacion CE; Chintapalli KN; Rees CR
    J Am Board Fam Pract; 1997; 10(5):315-21. PubMed ID: 9297655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical embolism associated with oral contraceptives: an underdiagnosed lesion?
    de Swiet J
    Postgrad Med J; 1979 Jun; 55(644):419-20. PubMed ID: 482190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and venous thromboembolism: a quantitative discussion of the uncertainties.
    Koster T; Small RA; Rosendaal FR; Helmerhorst FM
    J Intern Med; 1995 Jul; 238(1):31-7. PubMed ID: 7608644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptives, venous thrombosis, and varicose veins. Royal College of General Practitioners' Oral Contraception Study.
    J R Coll Gen Pract; 1978 Jul; 28(192):393-9. PubMed ID: 702453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden.
    Rintelen C; Mannhalter C; Ireland H; Lane DA; Knöbl P; Lechner K; Pabinger I
    Br J Haematol; 1996 May; 93(2):487-90. PubMed ID: 8639453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives, sex steroid-induced antibodies and vascular thrombosis: results from 1318 cases.
    Beaumont V; Lemort N; Beaumont JL
    Eur Heart J; 1991 Nov; 12(11):1219-24. PubMed ID: 1782953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
    Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
    N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptive use before and after the latest pill scare in The Netherlands. Changes in oral contraceptive use and how users change.
    de Vries CS; van den Berg PB; de Jong-van den Berg LT
    Contraception; 1998 Apr; 57(4):247-9. PubMed ID: 9649916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
    Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of thrombosis due to oral contraceptives: a further report.
    Maguire MG; Tonascia J; Sartwell PE; Stolley PD; Tockman MS
    Am J Epidemiol; 1979 Aug; 110(2):188-95. PubMed ID: 463873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraceptive choices in women with coagulation disorders.
    Comp PC; Zacur HA
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 2):1990-3. PubMed ID: 8512043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives].
    Bauersachs R; Lindhoff-Last E; Ehrly AM; Kuhl H
    Zentralbl Gynakol; 1996; 118(5):262-70. PubMed ID: 8701622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.